Disclosures for "Patient Demographics and Clinical Characteristics of Adults With Spinal Muscular Atrophy (SMA): An Assessment of Patients Receiving Risdiplam Treatment and Untreated Patients With SMA"
		
	
		- 
			
		
 
	
		- 
			Dr. Batech has received personal compensation for serving as an employee of Aetion, Inc. Dr. Batech has stock in Aetion, Inc.. 
		
 
	
		- 
			Dr. Carmona has nothing to disclose.
		
 
	
		- 
			Dr. Lee has nothing to disclose.
		
 
	
		- 
			Dr. Poll has nothing to disclose.
		
 
	
		- 
			Mr. Simpson has stock in Roche. 
		
 
	
		- 
			Dr. Edwards has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. Edwards has stock in F. Hoffmann-La Roche Ltd. 
		
 
	
		- 
			Dr. Sutherland has received personal compensation for serving as an employee of F. Hoffman La-Roche. Dr. Sutherland has stock in F. Hoffman La-Roche. 
		
 
	
		- 
			Chiara Marini-Bettolo has nothing to disclose.
		
 
	
		- 
			Prof. Walter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC. Prof. Walter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Prof. Walter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Prof. Walter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Edgewise. Prof. Walter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Walter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Walter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Prof. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Prof. Walter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharnext. Prof. Walter has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTC. Prof. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. 
		
 
	
		- 
			Dr. Jagut has nothing to disclose.
		
 
	
		- 
			Dr. Haberlova has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer, Sarepta, PTC, Biogen, Novartis. 
		
 
	
		- 
			Victoria Hodgkinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma. Victoria Hodgkinson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynacure. Victoria Hodgkinson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Victoria Hodgkinson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. 
		
 
	
		- 
			 The institution of Dr. Yiu has received research support from Biogen.  The institution of Dr. Yiu has received research support from Roche .  The institution of Dr. Yiu has received research support from PTC.  The institution of Dr. Yiu has received research support from Pfizer . 
		
 
	
		- 
			Dr. Murphy has nothing to disclose.
		
 
	
		- 
			Mr. Roe has nothing to disclose.
		
 
	
		- 
			Heather Gordish-Dressman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AGADA BioSciences. Heather Gordish-Dressman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TRiNDS, LLC. Heather Gordish-Dressman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rejuvenate Bio.  An immediate family member of Heather Gordish-Dressman has received intellectual property interests from a discovery or technology relating to health care. Heather Gordish-Dressman has received personal compensation in the range of $500-$4,999 for serving as a TACT Advisory Board Reviewer with TREAT-NMD.